HISERPIA Drug Patent Profile
✉ Email this page to a colleague
When do Hiserpia patents expire, and when can generic versions of Hiserpia launch?
Hiserpia is a drug marketed by Bowman Pharms and is included in one NDA.
The generic ingredient in HISERPIA is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HISERPIA?
- What are the global sales for HISERPIA?
- What is Average Wholesale Price for HISERPIA?
Summary for HISERPIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 1,188 |
| DailyMed Link: | HISERPIA at DailyMed |
US Patents and Regulatory Information for HISERPIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bowman Pharms | HISERPIA | reserpine | TABLET;ORAL | 009631-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bowman Pharms | HISERPIA | reserpine | TABLET;ORAL | 009631-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
